Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation.

Kotha, Nikhil V; Kumar, Abhishek; Nelson, Tyler J; Qiao, Edmund M; Qian, Alex S; Voora, Rohith S; McKay, Rana R; Stewart, Tyler F; Rose, Brent S

Kotha, Nikhil V; Kumar, Abhishek; Nelson, Tyler J; Qiao, Edmund M; Qian, Alex S; Voora, Rohith S; McKay, Rana R; Stewart, Tyler F; Rose, Brent S.

Afiliación

Kotha NV; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Kumar A; Veterans Affairs San Diego Healthcare System, San Diego, California.
Nelson TJ; Veterans Affairs San Diego Healthcare System, San Diego, California.
Qiao EM; Department of Radiation Oncology, Duke University, Durham, North Carolina.
Qian AS; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Voora RS; Veterans Affairs San Diego Healthcare System, San Diego, California.
McKay RR; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Stewart TF; Veterans Affairs San Diego Healthcare System, San Diego, California.
Rose BS; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.

Adv Radiat Oncol ; 7(1): 100836, 2022.

Article en En | MEDLINE | ID: mdl-35071834

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Adv Radiat Oncol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google